A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
Clinical trial NCT05268003 · TERMINATED
Trial details
- NCT number
- NCT05268003
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-07
- Primary completion
- 2026-04-21
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.